Satowa Suzuki

Dr. Satowa Suzuki


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
SSSatowa Suzuki
Satowa Suzuki
MOMamoru Ohnishi
Mamoru Ohnishi
MKMichiko Kawanishi
Michiko Kawanishi
MAMasato Akiba
Masato Akiba
MKMakoto Kuroda
Makoto Kuroda

20 October 2018 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
ATAtsuko Tsutsui
Atsuko Tsutsui
SSSatowa Suzuki
Satowa Suzuki
Antimicrobial resistance (AMR) is now recognized as a major threat to public health, and surveillance of AMR is essential for successful containment. In 2000, Japan Nosocomial Infections Surveillance (JANIS) Clinical Laboratory (CL) division has been launched as a voluntary AMR surveillance funded by the Ministry of Health, Labour and Welfare and managed by the National Institute of Infectious Diseases. In this study, we aimed to propose a model of sustainable national AMR surveillance which provides not only national AMR surveillance reports but also benchmarking reports to each hospital to facilitate infection control practices. JANIS CL division collects comprehensive specimen-based data complies with JANIS data format from participating hospitals each month. It had targeted only blood and cerebrospinal fluid samples but was expanded to all types of specimens in 2007 at revision of JANIS. The JANIS system interprets the antimicrobial susceptibility according to the same criteria and conducts removal of duplicates to allow accurate comparison between hospitals. Monthly feedback reports are created automatically within 48 h, while quarterly and annual reports are generated after data validation. At the beginning, 468 hospitals were enrolled in the JANIS CL division, but the number of hospitals that submitted data decreased to 210 (45%) in 2006. After surveillance revision in 2007, annual recruitment of hospitals was initiated and as of 2015, 1475 hospitals participated, and 1461 (99%) of them submitted data throughout the year. Nationwide surveillance data collected over the past decade revealed that the prevalence of methicillin-resistant Staphylococcus aureus has decreased since 2008, and that its prevalence is higher in the western part of Japan, where the number of hospitals per capita is higher than in the eastern part. JANIS CL division serves a model of sustainable national AMR surveillance system. Comprehensive data for all specimens promotes understanding of the sampling frequency and prevalence of AMR. As a well-established system for providing rich information to guide action both locally and nationally, JANIS may also be utilized for sharing AMR data globally.

30 September 2021 in Antibiotics
Verified
Journal Article
Open access
PDF file
SSSatowa Suzuki
Satowa Suzuki
The Ministry of Health, Labour and Welfare (MHLW) of Japan has conducted two national surveillance systems for approximately 20 years to monitor antimicrobial resistance (AMR) in bacteria: the National Epidemiological Surveillance of Infectious Diseases (NESID) and the Japan Nosocomial Infections Surveillance (JANIS). Data accumulated for 20 years by these two surveillance systems have helped depict the epidemiology of the representative AMR bacteria in Japan chronologically. The epidemiology of methicillin-resistant Staphylococcus aureus teaches us that once AMR bacteria have established their high endemicity, controlling such AMR bacteria requires time and is challenging. On the other hand, the epidemiology that multidrug-resistant Acinetobacter sp. exhibits when a strict containment policy for AMR bacteria was introduced in the early phase of its emergence and spread reveals that it is possible to control it. Detailed epidemiology provided by these two different national surveillance systems in Japan enabled us to set up the goal for controlling each AMR bacteria at the hospital level to the prefecture/national level. It is the public health authorities’ responsibility to maintain a good surveillance system for AMR bacteria and share the data and findings with healthcare professionals and academicians.

1 August 2011 in Journal of Hospital Infection
Verified
Journal Article
Closed access
ATA. Tsutsui
A. Tsutsui
SSSatowa Suzuki
Satowa Suzuki
KYK. Yamane
K. Yamane
MMM. Matsui
M. Matsui
TKT. Konda
T. Konda
YAY. Arakawa
Y. Arakawa

30 October 2019 in mSphere
Verified
Journal Article
Open access
PDF file
HKHiroaki Kubota
Hiroaki Kubota
YSYasunori Suzuki
Yasunori Suzuki
RORumi Okuno
Rumi Okuno
YUYumi Uchitani
Yumi Uchitani
TATsukasa Ariyoshi
Tsukasa Ariyoshi
KSKenji Sadamasu
Kenji Sadamasu
IMP-type metallo-β-lactamases comprise one group of the “Big 5” carbapenemases. Here, a novel bla IMP-68 gene encoding IMP-68 (harboring a Ser262Gly point mutant of IMP-11) was discovered from meropenem-resistant but imipenem-susceptible Klebsiella pneumoniae TA6363. The Ser262Gly substitution was previously identified as important for substrate specificity according to a study of other IMP variants, including IMP-6. We confirmed that IMP-68 exhibited weaker imipenem-hydrolyzing activity than that for other carbapenems, demonstrating that the antimicrobial susceptibility profile of TA6363 originated from IMP-68 substrate specificity, with this likely to affect treatment strategies using antibacterial agents in clinical settings. Notably, the carbapenem resistance conferred by IMP-68 was undetectable based on the MIC of imipenem as a carbapenem representative, which demonstrates a comparable antimicrobial susceptibility profile to IMP-6-producing Enterobacteriaceae that previously spread in Japan due to lack of awareness of its existence.

1 February 2017 in Journal of Microbiological Methods
Verified
Journal Article
Closed access
TSTakaya Segawa
Takaya Segawa
MMMari Matsui
Mari Matsui
MSMasato Suzuki
Masato Suzuki
ATAtsuko Tsutsui
Atsuko Tsutsui
MKMakoto Kuroda
Makoto Kuroda
SSSatowa Suzuki
Satowa Suzuki